Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
about
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogeneticsPharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variantsMolecular actions and clinical pharmacogenetics of lithium therapyBiological predictors of lithium response in bipolar disorder.Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.Response to lithium in bipolar disorder: clinical and genetic findings.Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study.Genetic factors and treatment of mood disorders.Lithium long-term treatment in mood disorders: clinical and genetic predictors.Pharmacogenetic aspects of bipolar disorder.The promise and reality of pharmacogenetics in psychiatryPharmacogenetics and mood stabilization in bipolar disorder.Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications.Pharmacogenetics and bipolar disorder.Neuropsychiatric pharmacogenetics: moving toward a comprehensive understanding of predicting risks and response.The emerging role of pharmacogenetics: implications for clinical psychiatry.Predictors of lithium response in bipolar disorder.Pharmacogenetics in mood disorder.Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.Treatment of bipolar disorder: new perspectives.Lithium: a key to the genetics of bipolar disorder.Lithium response across generations.Pharmacogenetic considerations in the treatment of psychiatric disorders.Predicting response to lithium in bipolar disorder: a critical review of pharmacogenetic studies.Pharmacogenomics of bipolar disorder.Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS).Polymorphism in the serotonin transporter gene and response to treatment in African American cocaine and alcohol-abusing individuals.Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes.Lithium response viewed as a biomarker to predict developmental psychopathology in offspring with bipolar disorder: a commentary.Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy.Prediction of response to drug therapy in psychiatric disorders.Evidence for association of anACCN1gene variant with response to lithium treatment in Sardinian patients with bipolar disorder
P2860
Q28081249-97BF9863-559A-4B69-96A4-005D22E49A95Q28216643-97090B80-7482-4499-A361-736531B0FB31Q28307770-A08CCC80-AFBC-4C67-B46D-4ADB1B8C6A98Q30794691-DE1AB2DF-D8F3-4A46-AADA-997D2DFDFC5CQ33183862-06663286-ACE7-4060-9BD2-21EA4407A658Q33777973-9DB87161-8FCB-4D96-B18B-4A04F1F017CAQ34131354-FBF5898A-89E4-4417-9079-390DDCAEB24BQ34146222-A899F461-CA6F-4570-A7BC-EE094A694823Q34291371-1958FB68-F190-4BD1-93D5-BCE404321DEBQ34530084-05D7EE92-A964-48B3-8725-8898086399A6Q34609171-347D1A24-F1F8-4570-BBE4-0F212D2DBB43Q35040884-EBE95987-5845-437A-84CB-A238BC986FE2Q35226451-9CE10413-A6DC-4CFD-B151-E5D2372E66D6Q35576960-A7F5C899-E0EB-41FF-A0C8-BE293C48A870Q35580587-894483AC-28AA-4645-B107-838E2E8CB59AQ35744024-F4FAF878-E1A1-4D3C-98D2-0D35949E316BQ35814369-955FB45B-A1E4-45E1-879B-464B9859A283Q35837661-A20426EE-5FF0-4EE1-8459-7B554FF4BBC6Q36443736-1992785E-FFE0-477B-BDCD-FF9013DCCCFFQ36460262-C040A6CF-96F7-4B76-A133-0A5A6677A87DQ36699480-45DD3C96-051C-491B-B2C5-B36014D3DEF7Q37280843-9E93E3E1-9D94-4A2E-845F-0862AF30305AQ37402610-1D4889B0-B5CE-4784-8355-8D6F6EC46FE3Q37609499-6906F842-2717-4FFE-99AA-49F58EEB8C4CQ37681573-F5FBC99C-0CC5-4786-87B7-ABA0CDDAA783Q37740131-48BA2E18-6271-48AC-A106-23FFBC09E556Q38097534-FB0FDE20-9677-4C14-B53A-53E1C9CAACC1Q38758778-F58AA53A-E014-4963-BB2B-163BA9D2AA1BQ42361493-3B1297C2-E768-4644-9146-4FB62B37EB38Q44866370-A94448E0-49EA-4F18-BFF4-E176BF5223ACQ45053879-C0EB5ED8-6F2C-4E9A-9A31-051FA1ABE0B6Q46658086-A28E5571-6529-48D4-A957-E1D6EE589F65Q48234559-89B87FD3-053F-4579-BE5A-545D68F1E9A0Q48406708-7BFB149C-D083-49A1-A7A4-8902AE3F1388Q48918376-95D5BEB9-9E61-444A-A30A-D68332C22816Q55002697-B941B4BA-6232-4003-A2F5-B8FEEC97C616Q58875291-8D1D5411-EC0E-460D-8285-AC4168915C0B
P2860
Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
@en
Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
@nl
type
label
Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
@en
Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
@nl
prefLabel
Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
@en
Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
@nl
P2093
P2860
P356
P1476
Serotonin transporter gene associated with lithium prophylaxis in mood disorders
@en
P2093
P2860
P2888
P356
10.1038/SJ.TPJ.6500006
P577
2001-01-01T00:00:00Z